Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6225)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lind L, Johansson L, Ahlström H, Eriksson JW, Larsson A, Risérus U, Kullberg J, Oscarsson J. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World J Hepatol 2020; 12(4): 149-159 [PMID: 32685107 DOI: 10.4254/wjh.v12.i4.149] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i4/149.htm |
| Number | Citing Articles |
| 1 |
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference. Journal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
|
| 2 |
Ilias D. Vachliotis, Maria F. Vasiloglou, Aikaterini Kapama, Dimitrios Matsagkos, Antonis Goulas, Paraskevi Papaioannidou, Stergios A. Polyzos. Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life. Arab Journal of Gastroenterology 2022; 23(4): 277 doi: 10.1016/j.ajg.2022.05.006
|
| 3 |
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
|
| 4 |
So-hyeon Hong, Yeon-Ah Sung, Young Sun Hong, Do Kyeong Song, Hyein Jung, Kyungah Jeong, Hyewon Chung, Hyejin Lee. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-39428-4
|
| 5 |
Christoph G Dietrich, Monika Rau, Andreas Geier. Screening for nonalcoholic fatty liver disease-when, who and how?. World Journal of Gastroenterology 2021; 27(35): 5803-5821 doi: 10.3748/wjg.v27.i35.5803
|
| 6 |
Jacob V. DiBattista, Daniel A. Burkholder, Anna S. Lok, Vincent L. Chen. Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort. Digestive Diseases and Sciences 2022; 67(11): 5300 doi: 10.1007/s10620-022-07415-w
|
| 7 |
Zahra Sadeghianpour, Bahman Cheraghian, Hamid Reza Farshchi, Mohsen Asadi-Lari. Non-alcoholic fatty liver disease and socioeconomic determinants in an Iranian cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02964-4
|
| 8 |
Taesic Lee, Tae-Ha Chung. Comparative analysis of the relationship between four hepatic steatosis indices and muscle mass. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28751-5
|
| 9 |
Katarzyna Marcinkiewicz, Anita Horodnicka-Józwa, Tomasz Jackowski, Kamila Strączek, Agnieszka Biczysko-Mokosa, Mieczysław Walczak, Elżbieta Petriczko. Nonalcoholic fatty liver disease in children with obesity– observations from one clinical centre in the Western Pomerania region. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.992264
|
| 10 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
|
| 11 |
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
|
| 12 |
Kadriye Bir Yücel, Atiye Cenay Karabörk Kilic, Osman Sütcüoglu, Ozan Yazıcı, Koray Kilic, Gözde Savaş, Aytug Uner, Nazan Günel, Ahmet Özet, Nuriye Özdemir. Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy. Journal of Chemotherapy 2024; 36(3): 249 doi: 10.1080/1120009X.2023.2246786
|
| 13 |
Junzhao Ye, Yansong Lin, Congxian Shao, Yanhong Sun, Shiting Feng, Bihui Zhong. Comparisons of Insulin Resistance- and Steatosis-Based Scores in Monitoring Metabolic Associated Fatty Liver Disease Treatment Response. Annals of Nutrition and Metabolism 2023; 79(5): 448 doi: 10.1159/000530531
|
| 14 |
Marcin Kosmalski, Józef Drzewoski, Izabela Szymczak-Pajor, Andrzej Zieleniak, Melania Mikołajczyk-Solińska, Jacek Kasznicki, Agnieszka Śliwińska. Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD). Biomedicines 2022; 10(9): 2253 doi: 10.3390/biomedicines10092253
|
| 15 |
C. Vikneshwaran Chandra Kumar, Ruben Skantha, Wah-Kheong Chan. Non-invasive assessment of metabolic dysfunction–associated fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 2022; 13: 204201882211396 doi: 10.1177/20420188221139614
|
| 16 |
Simon Blaschke, Nele Schad, Melina Schnitzius, Klaus Pelster, Filip Mess. The Connection between Non-Alcoholic Fatty-Liver Disease, Dietary Behavior, and Food Literacy in German Working Adults. Nutrients 2023; 15(3): 648 doi: 10.3390/nu15030648
|
| 17 |
José Alfonso Cortés Rubio, Diego Martín Acicoya, Marta Candela Fernández, Elena Alcanda Renquel, Adriana Vañó Garrido-Arroquia, M Cortés Costa. Validación del test FLI (Fatty Liver Index) para el diagnóstico de esteatosis hepática en pacientes con obesidad y/o diabetes mellitus para su utilización en Atención Primaria. Estudio FLIAP. Revista Clínica de Medicina de Familia 2023; : 325 doi: 10.55783/rcmf.160404
|
| 18 |
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
|
| 19 |
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
|
| 20 |
Daniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis. Annals of Hepatology 2023; 28(1): 100873 doi: 10.1016/j.aohep.2022.100873
|
| 21 |
Henriette Kreimeyer, Paul Manka, Ali Canbay. Praxisorientierte Strategien für Screening, Diagnostik und Therapie der NAFLD. Gastro-News 2023; 10(4): 31 doi: 10.1007/s15036-023-3265-4
|
| 22 |
Chang-Hoon Lee, Kyung-Do Han, Da Hye Kim, Min-Sun Kwak. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.638615
|
| 23 |
Matheus Mathedi CONCON, Martinho Antonio GESTIC, Murillo Pimentel UTRINI, Felipe David Mendonça CHAIM, Elinton Adami CHAIM, Everton CAZZO. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. Arquivos de Gastroenterologia 2022; 59(1): 110 doi: 10.1590/s0004-2803.202200001-19
|